Ligand Pharmaceuticals
LGND
#3725
Rank
A$5.20 B
Marketcap
A$264.28
Share price
-1.91%
Change (1 day)
37.36%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): A$93.08 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are A$0.25 Billion. In 2024 the company made an earning of A$7.87 Million a decrease over its 2023 earnings that were of A$91.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) A$93.08 M1082.21%
2024 A$7.87 M-91.37%
2023 A$91.22 M-7.59%
2022 A$98.72 M4%
2021 A$94.92 M296.42%
2020 A$23.94 M-97.97%
2019 A$1.18 B275.62%
2018 A$0.31 B237.48%
2017 A$93.13 M49.05%
2016 A$62.48 M55.41%
2015 A$40.2 M36.87%
2014 A$29.37 M29.59%
2013 A$22.66 M1309.35%
2012 A$1.6 M-43.97%
2011 A$2.87 M-113.19%
2010 -A$21.77 Million59.86%
2009 -A$13.62 Million-61.33%
2008 -A$35.21 Million-58.75%
2007 -A$85.36 Million20.52%
2006 -A$70.83 Million81.27%
2005 -A$39.07 Million
2003 -A$27.21 Million-20.6%
2002 -A$34.26 Million4.38%
2001 -A$32.82 Million-48.83%
2000 -A$64.14 Million-19.74%
1999 -A$79.91 Million-19.06%
1998 -A$98.73 Million126.71%
1997 -A$43.55 Million-5.83%
1996 -A$46.24 Million136.23%
1995 -A$19.58 Million-33.97%
1994 -A$29.65 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
A$45.95 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$16.81 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$31.91 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$11.69 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-A$0.39 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$32.75 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$11.39 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$13.22 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-A$87.78 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA